44 related articles for article (PubMed ID: 15864417)
1. Immunomodulation by mercuric chloride in vitro: application of different cell activation pathways.
Hemdan NY; Lehmann I; Wichmann G; Lehmann J; Emmrich F; Sack U
Clin Exp Immunol; 2007 May; 148(2):325-37. PubMed ID: 17302730
[TBL] [Abstract][Full Text] [Related]
2. Superiority of the ear pinna over a subcutaneous tumour inoculation site for induction of a Th1-type cytokine response.
Jurianz K; von Hoegen P; Schirrmacher V
Cancer Immunol Immunother; 1998 Feb; 45(6):327-33. PubMed ID: 9490203
[TBL] [Abstract][Full Text] [Related]
3. Low dose post-transplant cyclophosphamide and sirolimus induce mixed chimerism with CTLA4-Ig or lymphocyte depletion in an MHC-mismatched murine allotransplantation model.
Kabore MD; McElrath CC; Ali MAE; Almengo K; Gangaplara A; Fisher C; Barreto MA; Shaikh A; Olkhanud PB; Xu X; Gaskin D; Lopez-Ocasio M; Saxena A; McCoy JP; Fitzhugh CD
Bone Marrow Transplant; 2024 May; 59(5):615-624. PubMed ID: 38347187
[TBL] [Abstract][Full Text] [Related]
4. Rocaglamide Prolonged Allograft Survival by Inhibiting Differentiation of Th1/Th17 Cells in Cardiac Transplantation.
Dai C; Zhou X; Wang L; Tan R; Wang W; Yang B; Zhang Y; Shi H; Chen D; Wei L; Chen Z
Oxid Med Cell Longev; 2022; 2022():2048095. PubMed ID: 35087613
[TBL] [Abstract][Full Text] [Related]
5. Heart allograft tolerance without development of posttransplant cardiac allograft vasculopathy in chimerism-based, drug-induced tolerance.
Zhang QW; Tomita Y; Matsuzaki G; Shimizu I; Iwai T; Okano S; Minagawa R; Nakashima Y; Sueishi K; Nomoto K; Yasui H
Transplantation; 2002 Feb; 73(4):652-6. PubMed ID: 11889448
[TBL] [Abstract][Full Text] [Related]
6. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.
Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM
Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711
[TBL] [Abstract][Full Text] [Related]
7. Cytokine mRNA profiles in mouse orthotopic liver transplantation. Graft rejection is associated with augmented TH1 function.
Thai NL; Fu F; Qian S; Sun H; Gao L; Wang SC; Demetris AJ; Woo J; Thomson AW; Duquesnoy RJ
Transplantation; 1995 Jan; 59(2):274-81. PubMed ID: 7530874
[TBL] [Abstract][Full Text] [Related]
8. Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide.
Tomita Y; Yoshikawa M; Zhang QW; Shimizu I; Okano S; Iwai T; Yasui H; Nomoto K
J Immunol; 2000 Jul; 165(1):34-41. PubMed ID: 10861032
[TBL] [Abstract][Full Text] [Related]
9. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
[TBL] [Abstract][Full Text] [Related]
10. Absent mRNA accumulation of Th1 or Th2 cytokines in heart allografts with chimerism-based drug-induced tolerance.
Tomita Y; Zhang QW; Matsuzaki G; Shimizu I; Iwai T; Okano S; Nomoto K; Yasui H
Surg Today; 2005; 35(5):364-70. PubMed ID: 15864417
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide-induced chimera-type tolerance to allografts: an overview of drug-induced immunological tolerance.
Mayumi H; Tokunaga K
Fukuoka Igaku Zasshi; 1990 Jan; 81(1):20-39. PubMed ID: 2182492
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment of donor stimulator cells by 16,16 dimethyl prostaglandin E2 influences the recipient immune response.
Chung SW; Gould B; Zhang R; Hu Y; Levy GA; Gorczynski RM
Surgery; 1998 Feb; 123(2):171-80. PubMed ID: 9481403
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
